Japanese companies this year concluded 621 transactions for the acquisition of foreign assets totaling $180 billion. As reported by Dealogic, the figure for 2018 rose to a record high in more than 20 years. The $62 billion purchase of the Irish Shire by pharmaceutical company Takeda Pharmaceutical was the largest foreign asset acquisition in Japanese history. Japanese companies this year have increased their activity abroad against the background of the stagnation of the Japanese economy, caused mainly by the aging of the population. Hernan Kasterna, head of the global M & A division at JPMorgan, noted the more favorable position of Japanese companies when concluding transactions with foreign companies than their Chinese competitors, as Japanese companies face less stringent requirements from foreign regulators.